These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9303017)

  • 61. Cell cycle-dependent regulation of elastin gene in cultured chick vascular smooth-muscle cells.
    Wachi H; Seyama Y; Yamashita S; Tajima S
    Biochem J; 1995 Jul; 309 ( Pt 2)(Pt 2):575-9. PubMed ID: 7626022
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Smooth Muscle Lineage Diversity in the Chick Embryo.
    Topouzis S; Majesky MW
    Dev Biol; 1996 Sep; 178(2):430-45. PubMed ID: 8812140
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Exogenous and endogenous transforming growth factors-beta influence elastin gene expression in cultured lung fibroblasts.
    McGowan SE; Jackson SK; Olson PJ; Parekh T; Gold LI
    Am J Respir Cell Mol Biol; 1997 Jul; 17(1):25-35. PubMed ID: 9224206
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Media conditioned by smooth muscle cells cultured in a variety of hypoxic environments stimulates in vitro angiogenesis. A relationship to transforming growth factor-beta 1.
    Sakuda H; Nakashima Y; Kuriyama S; Sueishi K
    Am J Pathol; 1992 Dec; 141(6):1507-16. PubMed ID: 1281623
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Up-regulation of connexin43 correlates with increased synthetic activity and enhanced contractile differentiation in TGF-beta-treated human aortic smooth muscle cells.
    Rama A; Matsushita T; Charolidi N; Rothery S; Dupont E; Severs NJ
    Eur J Cell Biol; 2006 May; 85(5):375-86. PubMed ID: 16442184
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ubiquitous elevation of matrix metalloproteinase-2 expression in the vasculature of patients with abdominal aneurysms.
    Goodall S; Crowther M; Hemingway DM; Bell PR; Thompson MM
    Circulation; 2001 Jul; 104(3):304-9. PubMed ID: 11457749
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Data-Independent Acquisition-Based Serum Proteomic Profiling of Adult Moyamoya Disease Patients Reveals the Potential Pathogenesis of Vascular Changes.
    Wang Z; Ji C; Han Q; Wang Z; Huang Y
    J Mol Neurosci; 2022 Dec; 72(12):2473-2485. PubMed ID: 36520382
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical and immunopathological features of Moyamoya disease.
    Lin R; Xie Z; Zhang J; Xu H; Su H; Tan X; Tian D; Su M
    PLoS One; 2012; 7(4):e36386. PubMed ID: 22558457
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Role of basic fibroblast growth factor in the pathogenesis of moyamoya disease.
    Houkin K; Yoshimoto T; Abe H; Nagashima K; Nagashima M; Takeda M; Isu T
    Neurosurg Focus; 1998 Nov; 5(5):e2. PubMed ID: 17112205
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Expression of vascular endothelial growth factor in dura mater of patients with moyamoya disease.
    Sakamoto S; Kiura Y; Yamasaki F; Shibukawa M; Ohba S; Shrestha P; Sugiyama K; Kurisu K
    Neurosurg Rev; 2008 Jan; 31(1):77-81; discussion 81. PubMed ID: 17912564
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Linking cortical astrocytic neogenin deficiency to the development of Moyamoya disease-like vasculopathy.
    Ren X; Yao LL; Pan JX; Zhang JS; Mei L; Wang YG; Xiong WC
    Neurobiol Dis; 2021 Jul; 154():105339. PubMed ID: 33775822
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Moyamoya disease and transforming growth factor-beta1.
    Ueno M; Kira R; Matsushima T; Inoue T; Fukui M; Gondo K; Ihara K; Hara T
    J Neurosurg; 2000 May; 92(5):907-8. PubMed ID: 10794320
    [No Abstract]   [Full Text] [Related]  

  • 73. Cell-, age-, and phenotype-dependent differences in the control of gene expression.
    Stenmark KR
    Am J Physiol Lung Cell Mol Physiol; 2001 Oct; 281(4):L762-5. PubMed ID: 11557579
    [No Abstract]   [Full Text] [Related]  

  • 74. Circulating Vascular Progenitor Cells in Moyamoya Disease.
    Kang HS; Wang KC; Kim SK
    J Korean Neurosurg Soc; 2015 Jun; 57(6):428-31. PubMed ID: 26180610
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Correction to: Comprehensive Profiling of Secreted Factors in the Cerebrospinal Fluid of Moyamoya Disease Patients.
    Abhinav K; Lee AG; Pendharkar AV; Bigder M; Bet A; Rosenberg-Hasson Y; Cheng MY; Steinberg GK
    Transl Stroke Res; 2024 Jun; 15(3):688. PubMed ID: 36991240
    [No Abstract]   [Full Text] [Related]  

  • 76. Insights into the regulatory role of epigenetics in moyamoya disease: Current advances and future prospectives.
    Xu S; Chen T; Yu J; Wan L; Zhang J; Chen J; Wei W; Li X
    Mol Ther Nucleic Acids; 2024 Sep; 35(3):102281. PubMed ID: 39188306
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Molecular Biomarkers Affecting Moyamoya Disease.
    Tu YK; Fang YC
    Adv Tech Stand Neurosurg; 2024; 49():1-18. PubMed ID: 38700677
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Moyamoya disease in a 2-year-old patient from the middle east: a case report and literature review.
    Habes HMN; Alshareef RB; Amleh A; Doudin AAA; Habes YMN; Abdulrazzak M; Basal SI
    Ann Med Surg (Lond); 2024 May; 86(5):3066-3071. PubMed ID: 38694386
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identification of diagnostic markers for moyamoya disease by combining bulk RNA-sequencing analysis and machine learning.
    Xu Y; Chen B; Guo Z; Chen C; Wang C; Zhou H; Zhang C; Feng Y
    Sci Rep; 2024 Mar; 14(1):5931. PubMed ID: 38467737
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Physiological and pathophysiological mechanisms of the molecular and cellular biology of angiogenesis and inflammation in moyamoya angiopathy and related vascular diseases.
    Dorschel KB; Wanebo JE
    Front Neurol; 2023; 14():661611. PubMed ID: 37273690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.